Phase II study of CGP 69846A (ISIS 5132) in recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116). (Q44403055)
Jump to navigation
Jump to search
scientific article published in April 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of CGP 69846A (ISIS 5132) in recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116). |
scientific article published in April 2003 |
Statements
1 reference
Phase II study of CGP 69846A (ISIS 5132) in recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116). (English)
1 reference
A M Oza
1 reference
L Elit
1 reference
K Swenerton
1 reference
W Faught
1 reference
P Ghatage
1 reference
M Carey
1 reference
L McIntosh
1 reference
A Dorr
1 reference
J T Holmlund
1 reference
E Eisenhauer
1 reference
NCIC Clinical Trials Group Study (NCIC IND.116)
1 reference
1 April 2003
1 reference
1 reference
89
1 reference
1
1 reference
129-133
1 reference
Identifiers
1 reference
1 reference